◀ Back to IRF6
IRF6 — JAK1
Text-mined interactions from Literome
Stoiber et al., J Immunol 1999
:
A causal link of decreased IFN-gamma signaling to SOCS3 induction was also suggested by the
LPS dependent reduction of IFN-gamma mediated
Janus kinase 1 (JAK1) activation
Severgnini et al., Am J Physiol Lung Cell Mol Physiol 2004
(Acute Disease...) :
We also demonstrated that
LPS activates both the STAT kinases, Src and
JAK , in the lung with kinetics that are consistent with STAT activation
Liu et al., Zhonghua Shao Shang Za Zhi 2005
:
In addition, the cells were divided into normal control,
LPS stimulation,
JAK2 inhibition ( with AG490 treatment 2 hours before LPS stimulation ), STAT1 inhibition ( with fludarabine treatment 2 hours before LPS stimulation ) and STAT3 inhibition ( with rapamycin treatment 2 hours before LPS stimulation ) groups
Wu et al., Br J Pharmacol 2009
:
Effects of tripterine were investigated on endothelial barrier function, inducible nitric oxide synthase (iNOS) expression, nicotinamide adenine dinucleotide phasphate ( NADPH ) oxidase activity, 3-nitrotyrosine formation, protein phosphatase type 2A (PP2A) activity,
activation of extracellular regulated kinase (ERK), c-Jun terminal kinase (JNK) and
Janus kinase ( Jak2 ), and degradation of IkappaB in microvascular endothelial cells exposed to pro-inflammatory stimulus [
lipopolysaccharide (LPS) + interferon gamma (IFNgamma) ] and on vascular permeability in air pouches of mice injected with LPS + IFNgamma
Gorina et al., Glia 2011
:
LPS also
induced delayed
Jak1/Stat1 activation, which was MyD88 independent but was not mediated by IFN-ß